The United States generic drug market was valued at USD 163.68 Billion in 2024, driven by rising demand for affordable medications and patent expiries. The market is projected to grow at a CAGR of 12.00% during 2025–2034, reaching USD 508.37 Billion by 2034. Cost-effectiveness and growing chronic disease prevalence are major contributors to market expansion. https://www.expertmarketresearch.com/reports/united-states-generic-drug-market